|Author (Corporate)||European Commission: DG Health and Food Safety|
|Series Details||COM (2020) 725|
|Content Type||Blog, Policy-making|
Legislative initiative tabled by the European Commission on 11 November 2020, aimed at extending the mandate of the European Medicines Agency (EMA).
The COVID-19 (coronavirus) pandemic highlighted the limited ability of the European Union (EU) to coordinate work to ensure the availability of medicinal products and medical devices and facilitate their development. It became clear that the EMA requires a framework to be deployed in preparation for and during public health emergencies and other major events to improve the EU's capacity to react quickly, efficiently, and in a coordinated manner to such emergencies. The general objectives of the legislative proposal are to:
It was tabled by the European Commission on 11 November 2020, alongside a Communication setting out the first elements of a European Health Union. The Council of the European Union adopted its general approach on 15 June 2021, followed by the plenary of the European Parliament on 8 July.
|Subject Tags||Public Health|
|International Organisations||European Union [EU]|